Andrew Walker

Andrew Walker

Equities remain near record highs even as the 10-year yield climbed from 4.2% to 5.1% by September 24, suggesting rates’ financial gravity may be operating with a long fuse.As 2021-23 debt reaches 2028-31 refinancing, replacing 3.5% coupons with 8-10% could expose overstated free cash flow, while higher discount rates reduce special-situation spreads and may leave a more brittle market.

Andrew Walker

With 10-year Treasuries and ERP around 4.5%, Walker warns that ERP returning to 6% could sharply compress P/E multiples.Higher rates could raise data-center lease requirements 5–10% and reduce 15-year contract terminal values, while tenant bankruptcy, Bitcoin-mining economics, or founder-driven capital allocation at UWMC and Cogent remain risks to monitor.

Andrew Walker × David Thomas

Fairfax delivered a 19.2% cumulative annual return from 1985 through 2024 as insurance, investments, and non-insurance operations evolved into three concurrent earnings engines after costly lessons in under-reserving and hedging.Buybacks have retired more than 20% of shares but recently slowed; succession and the 15% long-term book-value-growth objective now test whether this second wind can outlast Fairfax’s “seven lean years, seven fat years” rhythm.

Andrew Walker × Andrei Stetsenko

Maharashtra Scooters offers roughly $4 billion of listed Bajaj shares and no debt at about 50% of marked NAV, while earnings growth—not liquidation—underpins the thesis.Bajaj Finance and Bajaj Finserv provide exposure to underpenetrated lending, insurance, and asset management; SEBI reforms and Bajaj Holdings’ recent share sales could narrow the discount, but collection discipline and cyclical growth remain central risks.

Andrew Walker × Byrne Hobart

Early Buffett’s repeatable edge was “cigar butts plus control” or buying businesses amid company-specific distress, not simply owning mature compounders.Sanborn Map and Dempster Mill show activism and liquidation supplying the catalyst, while GEICO and The Washington Post illustrate crisis-created entry prices.Salomon and LTCM suggest crisis expertise could become valuable, but the missed roughly $3 billion immediate LTCM opportunity highlights execution risk.

Andrew Walker

Markets recovered from the roughly 10% “Liberation Day” drop, but delayed plants, stores, deals, and capital spending leave tariff policy and recession risk unresolved.AI may commoditize quantitative work and 10-K comparison, making judgment and real-time management assessment scarcer despite meetings that expose investors to elite salesmanship.Biotech optionality can vanish after 50% clinical odds, time discounting, trial costs, and roughly $50 million annual overhead when incentives favor continued spending.

Andrew Walker × Byrne Hobart

Irwin’s history finds tariffs imposed deadweight loss but often “not that big a deal,” while containerization and integrated intermediate-goods networks make that reassurance an imperfect guide to today.Protection then becomes a slow political attrition contest favoring marginal producers, with Trump’s unusual Republican alignment, presidential discretion, and the unmeasured value of US security and dollar assets leaving modern incidence and durability unresolved.

Andrew Walker × Byrne Hobart

Expertise offered a probabilistic edge, not immunity from error, as the manager’s March 2008 calls show.Systemic crisis emerged when uncertainty over AAA collateral seized financial plumbing, while cheap funding scaled tiny credit-pricing errors into concentrated books.Hobart says AI economics do not support capex, though shorter asset duration may limit losses; peak spending could be depreciated by 2030 or 2031.